Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Dijie Zheng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5041698474. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2022: 4 papers · 2023: none · 2024: none · 2025: 5 papers · 2026: 1 paper

Papers 10

  1. HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation. Co-author DOI 10.1007/s00535-026-02457-7↗
  2. TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4. First author DOI 10.1016/j.drup.2024.101171↗
  3. CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance. Co-author DOI 10.1038/s41419-025-07399-1↗
  4. ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer. Co-author DOI 10.1038/s41419-025-08061-6↗
  5. Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression. Co-author DOI 10.1186/s12935-025-03645-w↗
  6. INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism. Co-author DOI 10.1186/s12935-025-03984-8↗
  7. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis. Co-author DOI 10.1038/s41419-022-04669-0↗
  8. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling path… Co-author DOI 10.1038/s41419-022-05379-3↗
  9. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma. First author DOI 10.1186/s12885-022-10128-y↗
  10. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway. Co-author DOI 10.1186/s12967-022-03749-1↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiwei He · 8 shared papers, 2022–2025 · strength 1.80
  2. Chao Yu · 4 shared papers, 2022–2025 · strength 0.86
  3. Futang Li · 3 shared papers, 2025–2026 · strength 0.84
  4. Changhao Wu · 3 shared papers, 2025 · strength 0.81
  5. Xinghao Sun · 3 shared papers, 2025–2026 · strength 0.79
  6. Kun Cai · 4 shared papers, 2022 · strength 0.68
  7. Chao Yu · 2 shared papers, 2022–2025 · strength 0.43
  8. Chao Yu · 2 shared papers, 2022–2025 · strength 0.41
  9. Shiyu Chen · 2 shared papers, 2022 · strength 0.32
  10. Yanqing Liu · 2 shared papers, 2022 · strength 0.32
  11. Cheng-Yi Sun · 2 shared papers, 2022 · strength 0.32
  12. Liwen Chen · 1 shared paper, 2026 · strength 0.30
  13. Chao Yu · 1 shared paper, 2026 · strength 0.30
  14. Zhirui Zeng · 1 shared paper, 2025 · strength 0.28
  15. Chao Yuan Yu · 1 shared paper, 2025 · strength 0.27
  16. Hao Hua · 1 shared paper, 2025 · strength 0.27
  17. Yongning Li · 1 shared paper, 2025 · strength 0.26
  18. Lin Li · 1 shared paper, 2022 · strength 0.19
  19. Yufei Zhu · 1 shared paper, 2022 · strength 0.17
  20. Lin Li · 1 shared paper, 2022 · strength 0.16
  21. Lin Li · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.